Sea Anemone Kunitz Peptide HCIQ2c1: Structure, Modulation of TRPA1 Channel, and Suppression of Nociceptive Reaction In Vivo
Authors:
- Aleksandra N. KvetkinaAKAleksandra N. Kvetkina
- Sergey D. OreshkovSOSergey D. Oreshkov
- Pavel A. MironovPavel A. Mironov
- Maxim M. ZaigraevMZMaxim M. Zaigraev
- Anna A. KlimovichAKAnna A. Klimovich
- Yulia V. DeriavkoYDYulia V. Deriavko
- Aleksandr S. MenshovAMAleksandr S. Menshov
- Dmitrii S. KulbatskiiDKDmitrii S. Kulbatskii
- Yulia A. LogashinaYLYulia A. Logashina
- Yaroslav A. AndreevYAYaroslav A. Andreev
- Anton O. ChugunovAnton O. Chugunov
- Mikhail P. KirpichnikovMKMikhail P. Kirpichnikov
Open Access
- 2 December 2024
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 22 (12) , 542
Abstract
TRPA1 is a homotetrameric non-selective calcium-permeable channel. It contributes to chemical and temperature sensitivity, acute pain sensation, and development of inflammation. HCIQ2c1 is a peptide from the sea anemone Heteractis magnifica that inhibits serine proteases. Here, we showed that HCIQ2c1 significantly reduces AITC- and capsaicin-induced pain and inflammation in mice. Electrophysiology recordings in Xenopus oocytes expressing rat TRPA1 channel revealed that HCIQ2c1 binds to open TRPA1 and prevents its transition to closed and inhibitor-insensitive ‘hyperactivated’ states. NMR study of the 15N-labeled recombinant HCIQ2c1 analog described a classical Kunitz-type structure and revealed two dynamic hot-spots (loops responsible for protease binding and regions near the N- and C-termini) that exhibit simultaneous mobility on two timescales (ps–ns and μs–ms). In modelled HCIQ2c1/TRPA1 complex, the peptide interacts simultaneously with one voltage-sensing-like domain and two pore domain fragments from different channel’s subunits, and with lipid molecules. The model explains stabilization of the channel in the open conformation and the restriction of ‘hyperactivation’, which are probably responsible for the observed analgetic activity. HCIQ2c1 is the third peptide ligand of TRPA1 from sea anemones and the first Kunitz-type ligand of this channel. HCIQ2c1 is a prototype of efficient analgesic and anti-inflammatory drugs.Keywords
Funding Information
- Russian Science Foundation (22-14-00326)
This publication has 86 references indexed in Scilit:
- A Tarantula-Venom Peptide Antagonizes the TRPA1 Nociceptor Ion Channel by Binding to the S1–S4 Gating DomainCurrent Biology, 2014
- Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networksJournal of Biomolecular NMR, 2013
- Structure and function of invertebrate Kunitz serine protease inhibitorsDevelopmental & Comparative Immunology, 2013
- A bifunctional sea anemone peptide with Kunitz type protease and potassium channel inhibiting propertiesBiochemical Pharmacology, 2011
- Accelerated NMR Spectroscopy by Using Compressed SensingAngewandte Chemie International Edition, 2011
- Cyanogen bromide cleavage of proteins in salt and buffer solutionsAnalytical Biochemistry, 2010
- Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugsPflügers Archiv - European Journal of Physiology, 2009
- Canonical protein inhibitors of serine proteasesCellular and Molecular Life Sciences, 2003
- The Interaction of Disagregin with the Platelet Fibrinogen Receptor, Glycoprotein IIb-IIIaBiochemical and Biophysical Research Communications, 1997
- Knowledge‐based protein secondary structure assignmentProteins: Structure, Function, and Bioinformatics, 1995